Point72 Asset Management
IDYA icon

Point72 Asset Management’s IDEAYA Biosciences IDYA Stock Holding History

Point72 Asset Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.9M Sell
327,901
-1,516,655
-82% -$50.9M 0.01% 1179
2025
Q4 		$63.8M Sell
1,844,556
-1,971,148
-52% -$62.8M 0.07% 318
2025
Q3 		$104M Sell
3,815,704
-1,212,575
-24% -$29.3M 0.17% 117
2025
Q2 		$106M Buy
5,028,279
+4,888,154
+3,488% +$93.8M 0.21% 113
2025
Q1 		$2.3M Buy
+140,125
New +$2.99M 0.01% 1202
2023
Q2 		– Sell
-5,265
Closed -$72.3K – 2447
2023
Q1 		$72.3K Buy
5,265
+2,584
+96% +$43K ﹤0.01% 1698
2022
Q4 		$48.7K Buy
+2,681
New +$45.1K ﹤0.01% 1336
2022
Q3 		– Sell
-1,509,000
Closed -$20.8M – 1536
2022
Q2 		$20.8M Sell
1,509,000
-338,017
-18% -$3.76M 0.09% 304
2022
Q1 		$20.7M Buy
1,847,017
+496,617
+37% +$7.32M 0.08% 316
2021
Q4 		$31.9M Buy
1,350,400
+367,200
+37% +$8.53M 0.13% 225
2021
Q3 		$25.1M Buy
983,200
+293,255
+43% +$6.85M 0.11% 250
2021
Q2 		$14.5M Sell
689,945
-143,755
-17% -$2.95M 0.07% 360
2021
Q1 		$19.6M Sell
833,700
-277,411
-25% -$5.36M 0.09% 270
2020
Q4 		$15.6M Sell
1,111,111
-45,553
-4% -$617K 0.08% 340
2020
Q3 		$14.5M Buy
1,156,664
+147,400
+15% +$1.83M 0.07% 332
2020
Q2 		$14.3M Buy
1,009,264
+811,649
+411% +$6.39M 0.09% 263
2020
Q1 		$814K Hold
197,615
– – 0.01% 621
2019
Q4 		$1.48M Hold
197,615
– – 0.01% 661
2019
Q3 		$1.78M Buy
197,615
+2,048
+1% +$15.6K 0.01% 611
2019
Q2 		$1.95M Buy
+195,567
New +$2.13M 0.01% 657

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Point72 Asset Management's IDYA Position: Q1 2026 in Review

Point72 Asset Management reduced its IDEAYA Biosciences (IDYA) stake by 82% in Q1 2026, selling an estimated $50.9M and leaving 327,901 shares worth $10.9M. The position accounts for 0.01% of the portfolio, ranked #1179.

Point72 Asset Management first reported a position in IDYA in Q2 2019 and has held it in 20 quarters since. The position peaked at $106M in Q2 2025. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Point72 Asset Management held 327,901 shares of IDEAYA Biosciences worth $10.9M as of Q1 2026.
  • Point72 Asset Management sold 1,516,655 IDEAYA Biosciences shares in Q1 2026, an estimated $50.9M.
  • IDEAYA Biosciences made up 0.01% of Point72 Asset Management's portfolio in Q1 2026, its #1179 holding.
  • Point72 Asset Management first reported a position in IDEAYA Biosciences in Q2 2019 and has held it in 20 quarters since.
  • Point72 Asset Management's IDEAYA Biosciences position peaked at $106M in Q2 2025.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.